Skip to main content
Back
Watch Compare

Insight Molecular Diagnostics Inc.

Data quality: 100%
IMDX
Nasdaq Manufacturing Chemicals
$3.17
▼ $0.01 (-0.31%)
Mkt Cap: 99.40 M
Price
$3.09
Mkt Cap
99.40 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue declined -14.89% annually over 5 years
Negative free cash flow of -25.37 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 130.47%
Capital intensive — 78.55% of revenue goes to capex

Growth

Revenue Growth (5Y)
-14.89%
Below sector avg (1.82%)
Revenue (1Y)115.58%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-100.79%
Net Margin-1238.52%
Op. Margin-1260.76%

Safety

Debt / Equity
N/A
Current Ratio2.79
Interest Coverage-469.03

Valuation

PE (TTM)
-1.98
Below sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -2.0 -1.5
P/B — 1.6
ROE % — -53.5
Net Margin % -1238.5 -41.5
Rev Growth 5Y % -14.9 1.8
D/E — 0.3

Analyst Price Target

3 analysts
Buy
Current
$3.17
+162.9%
Target
$8.33
$4.00
$9.00
$12.00
Forecast
Forward EPS -$0.87
Est. Revenue 8.17 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.87
-$0.96 – -$0.79
 8.17 M 4
FY2026 -$0.75
-$1.03 – -$0.21
 2.58 M 4

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.24 -$0.72 -203.2%
Q32025 -$0.24 -$0.23 +2.8%
Q22025 -$0.24 -$0.30 -25.0%
Q12025 -$0.25 -$0.23 +9.8%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 115.58% Revenue Growth (3Y) 64.25%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -14.89% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.06 M Net Income (TTM) -50.22 M
ROE N/A ROA -106.34%
Gross Margin 56.67% Operating Margin -1260.76%
Net Margin -1238.52% Free Cash Flow (TTM) -25.37 M
ROIC -100.79% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2.79
Interest Coverage -469.03 Asset Turnover 0.09
Working Capital 13.73 M Tangible Book Value -23.80 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.98 Forward P/E N/A
P/B Ratio N/A P/S Ratio 24.51
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -25.52%
Market Cap 99.40 M Enterprise Value 80.71 M
Per Share
EPS (Diluted TTM) -1.65 Revenue / Share 0.13
FCF / Share -0.79 OCF / Share -0.69
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 78.55% FCF Conversion 50.51%
SBC-Adj. FCF -27.32 M Growth Momentum 130.47

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4.06 M 1.88 M 1.50 M 958,000.0 7.73 M
Net Income -50.22 M -60.66 M -27.78 M -72.90 M -64.10 M
EPS (Diluted) -1.65 -4.66 -3.75 — —
Gross Profit 2.30 M 740,000.0 413,000.0 -18,000.0 188,000.0
Operating Income -51.12 M -61.04 M -25.14 M -18.00 M -74.21 M
EBITDA — — — — —
R&D Expenses 15.90 M 9.84 M 9.29 M 7.30 M 13.63 M
SG&A Expenses — — — — —
D&A 2.20 M 1.56 M 1.59 M 1.50 M 844,000.0
Interest Expense -109,000.0 -84,000.0 -52,000.0 -77,000.0 -209,000.0
Income Tax 0.0 0.0 — -9.26 M -9.26 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 25.76 M 35.08 M 74.89 M 100.09 M 159.56 M
Total Liabilities 57.22 M 47.36 M 49.30 M 60.50 M 94.35 M
Shareholders' Equity -31.46 M -12.27 M 20.47 M 34.29 M 65.22 M
Total Debt — — — — —
Cash & Equivalents 11.58 M 8.64 M 9.43 M 19.99 M 35.61 M
Current Assets 15.31 M 11.76 M 10.70 M 25.54 M 39.14 M
Current Liabilities 12.08 M 7.28 M 7.19 M 12.11 M 14.12 M